SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ANGEL STEPHEN F

(Last)

(First)

(Middle)

C/O LINDE PLC

THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD

(Street)

GUILDFORD, SURREY

GU2 7XY

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2020

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares								2,268	I	In trust for children
Ordinary Shares								71,029	I	Angel Descendants Trust
Ordinary Shares								20,517	I	2012 Descendants Trust
Ordinary Shares								10,828.343	I	401(k)
Ordinary Shares	03/16/2020		P		2,000	A	$152.47⁽¹⁾	201,952	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0⁽²⁾							⁽²⁾	⁽²⁾	Ordinary Shares	13,935		13,935	D
Restricted Stock Units	$0⁽³⁾							⁽³⁾	⁽³⁾	Ordinary Shares	15,755		15,755	D
Restricted Stock Units	$0⁽⁴⁾							⁽⁴⁾	⁽⁴⁾	Ordinary Shares	38,270		38,270	D
Restricted Stock Units	$0⁽⁵⁾							⁽⁵⁾	⁽⁵⁾	Ordinary Shares	29,580		29,580	D
Restricted Stock Units	$0⁽⁶⁾							⁽⁶⁾	⁽⁶⁾	Ordinary Shares	47,632		47,632	D
Restricted Stock Units	$0⁽⁵⁾							⁽⁵⁾	⁽⁵⁾	Ordinary Shares	30,215		30,215	D
Restricted Stock Units	$0⁽⁶⁾							⁽⁶⁾	⁽⁶⁾	Ordinary Shares	32,580		32,580	D
Stock Option (right to buy)	$173.13							⁽⁷⁾	03/09/2030	Ordinary Shares	169,560		169,560	D
Stock Option (right to buy)	$110.58							⁽⁸⁾	02/26/2023	Ordinary Shares	187,015		187,015	D
Stock Option (right to buy)	$128.8							⁽⁸⁾	02/25/2024	Ordinary Shares	203,930		203,930	D
Stock Option (right to buy)	$128.38							⁽⁸⁾	02/24/2025	Ordinary Shares	261,075		261,075	D
Stock Option (right to buy)	$102.22							⁽⁹⁾	02/23/2026	Ordinary Shares	416,355		416,355	D
Stock Option (right to buy)	$118.71							⁽¹⁰⁾	02/28/2027	Ordinary Shares	435,850		435,850	D
Stock Option (right to buy)	$154							⁽¹¹⁾	02/27/2028	Ordinary Shares	318,780		318,780	D
Stock Option (right to buy)	$176.63							⁽¹²⁾	03/20/2029	Ordinary Shares	177,605		177,605	D
Deferred Stock Units	$0⁽¹³⁾							⁽¹⁴⁾	⁽¹⁴⁾	Ordinary Shares	223.837		107,951.127	D

Explanation of Responses:

1. The price reported is the weighted average purchase price per share. The per share purchase prices ranged from $152.34 to $152.58. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

2. Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.

3. Restricted Stock Units that will vest in full and payout on March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis.

4. Restricted Stock Units that will vest in full and payout on February 27, 2021 in Linde plc Ordinary Shares on a one-for-one basis.

5. Restricted Stock Units that have vested in full but whose payout has been deferred to a future date.

6. Restricted Stock Units that will vest in full and payout on February 28, 2020 in Linde plc Ordinary Shares on a one-for-one basis.

7. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

8. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

9. This option vests over three years in three consecutive equal annual installments beginning February 23, 2017.

10. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.

11. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.

12. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

13. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

14. Deferred Stock Units acquired under the Compensation Deferral Plan ("Deferral Plan") that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.

Remarks:

	Anthony M. Pepper, Attorney-in-Fact	03/17/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.